Geode Capital Management’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Geode Capital Management’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-156,354	Closed	-$6.45M	–	4169
2015 Q2	$6.45M	Buy	156,354 +6,782	+5%	+$243K	﹤0.01%	1730
2015 Q1	$5.27M	Buy	149,572 +1,486	+1%	+$50.3K	﹤0.01%	1832
2014 Q4	$4.76M	Buy	148,086 +4,156	+3%	+$120K	﹤0.01%	1847
2014 Q3	$4.04M	Buy	143,930 +2,274	+2%	+$69.3K	﹤0.01%	1899
2014 Q2	$4.28M	Buy	141,656 +476	+0.3%	+$13.1K	﹤0.01%	1889
2014 Q1	$3.91M	Buy	141,180 +14,305	+11%	+$374K	﹤0.01%	1930
2013 Q4	$3.24M	Buy	126,875 +8,671	+7%	+$267K	﹤0.01%	2002
2013 Q3	$3.53M	Buy	118,204 +10,365	+10%	+$288K	﹤0.01%	1813
2013 Q2	$3.1M	Buy	+107,839	New	+$2.97M	﹤0.01%	1763

Other funds holding BRLI

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Geode Capital Management's BRLI Position: Q3 2015 in Review

Geode Capital Management sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 156,354 shares — an estimated $6.45M sold.

Geode Capital Management first reported a position in BRLI in Q2 2013 and held it in 9 quarters. The position peaked at $6.45M in Q2 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

Geode Capital Management reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
Geode Capital Management sold 156,354 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $6.45M.
Geode Capital Management first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 9 quarters.
Geode Capital Management's BIO-REFERENCE LABS INC-NEW- position peaked at $6.45M in Q2 2015.
1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Geode Capital Management's 13F filing for Q3 2015, filed 13 Nov 2015.